XML 77 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Income from loans and other investments:        
Interest and related income $ 6,763 $ 32,554 $ 21,479 $ 69,545
Less: Interest and related expenses 5,413 32,296 28,754 58,543
Income from loans and other investments, net 1,350 258 (7,275) 11,002
Other revenues:        
Management fees from affiliates 1,610 1,595 3,195 3,174
Servicing fees 1,365 438 3,385 748
Total other revenues 2,975 2,033 6,580 3,922
Other expenses:        
General and administrative 4,740 4,649 9,052 14,928
Total other expenses 4,740 4,649 9,052 14,928
Total other-than-temporary impairments of securities          (4,933)
Portion of other-than-temporary impairments of securities recognized in other comprehensive income       (160) (3,271)
Net impairments recognized in earnings       (160) (8,204)
Recovery of loan losses    8,088 8 17,249
Valuation allowance on loans held-for-sale    (224)    (224)
Gain on extinguishment of debt    937    250,976
Fair value adjustment on investment in CT Legacy Assets 3,704    7,657   
Gain on deconsolidation of subsidiary       146,380   
Income from equity investments 205 842 901 1,797
Income before income taxes 3,494 7,285 145,039 261,590
Income tax provision 143 1,061 1,066 1,450
Net income 3,351 6,224 143,973 260,140
Less: Net income attributable to noncontrolling interests (1,068) (8,069) (75,137) (7,400)
Net income (loss) attributable to Capital Trust, Inc. $ 2,283 $ (1,845) $ 68,836 $ 252,740
Net income (loss) per share of common stock:        
Basic $ 0.10 $ (0.08) $ 3.01 $ 11.19
Diluted $ 0.09 $ (0.08) $ 2.83 $ 10.52
Weighted average shares of common stock outstanding:        
Basic 22,893,522 22,723,146 [1] 22,865,819 22,580,143
Diluted 24,426,857 22,723,146 [1] 24,353,388 24,024,222
[1] Diluted EPS excludes 3.5 million warrants which were not dilutive for the period. These instruments could potentially impact Diluted EPS in future periods, depending on changes in our stock price.